# Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer

> **NCT02607540** · PHASE3 · UNKNOWN · sponsor: **The First Affiliated Hospital of Henan University of Science and Technology** · enrollment: 210 (estimated)

## Conditions studied

- Stage III Esophageal Squamous Cell Carcinoma
- Stage II Esophageal Squamous Cell Carcinoma

## Interventions

- **OTHER:** 2 cycles cisplatin-5-fluorouracil
- **OTHER:** 4 cycles cisplatin-5-fluorouracil
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02607540
- **Lead sponsor:** The First Affiliated Hospital of Henan University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2017-12
- **Final completion:** 2020-12
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2016-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607540, "Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT02607540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*